Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study

Purpose: To evaluate the long-term efficacy and safety of secukinumab in pediatric patients with generalized pustular psoriasis (GPP).Materials and methods: A retrospective study was conducted from July 2021 to July 2024, including 10 children with GPP. Patients were divided into two age groups: chi...

Full description

Bibliographic Details
Published in:	Journal of Dermatological Treatment
Main Authors:	Lu Xing, Lingsheng Long, Tao Wu, Lingrui Yin, Li Yu, Jingnan Wu, Danchen Li, Limin Miao, Hong Shu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Generalized pustular psoriasis GPP interleukin 17 pediatric long-term secukinumab
Online Access:	https://www.tandfonline.com/doi/10.1080/09546634.2024.2443121

Similar Items

Successful Treatment of Pediatric Generalized Pustular Psoriasis with Secukinumab
by: Yu K, et al.
Published: (2025-01-01)

Paradoxical pustular psoriasis in a patient with spondyloarthritis treated with secukinumab
by: Daniela Anghel, et al.
Published: (2023-12-01)

Secukinumab-induced paradoxical palmoplantar pustular psoriasis
by: Yıldız Gürsel Ürün, et al.
Published: (2022-12-01)

Case report: Successful treatment of acute generalized pustular psoriasis of puerperium with secukinumab
by: Gao Xue, et al.
Published: (2022-12-01)

Clinical efficacy and safety of secukinumab in the treatment of generalized pustular psoriasis in the pediatric population: a systematic review of the literature
by: Kebo Wei, et al.
Published: (2024-08-01)

Relapsing polychondritis associated with pustular psoriasis successfully treated with secukinumab: a case-based review
by: Qicheng Song, et al.
Published: (2024-07-01)

Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice
by: Anna Balato, et al.
Published: (2023-12-01)

Clinical analysis of secukinumab in the treatment of childhood generalized pustular psoriasis
by: Min YU, et al.
Published: (2024-04-01)

Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report
by: Lu X, et al.
Published: (2023-07-01)

Successful treatment of generalized pustular psoriasis during pregnancy with secukinumab in a patient hypersensitive to spesolimab: a case report
by: Shuang Zhang, et al.
Published: (2025-12-01)

Comparative Efficacy and Safety of Ustekinumab and Secukinumab in the Treatment of Generalized Pustular Psoriasis: A 48-Week Retrospective Cohort Study with Genetic Background Analysis
by: Ruan SF, et al.
Published: (2024-09-01)

Secukinumab – first in class interleukin-17A inhibitor for the treatment of psoriasis
by: Kiran Godse
Published: (2017-01-01)

The update of treatment strategies in pediatrics with generalized pustular psoriasis in China
by: Yunliu Chen, et al.
Published: (2023-09-01)

Serious generalized pustular psoriasis with evolution to plaque psoriasis: approach with spesolimab
by: Liz S. Gea, et al.
Published: (2024-10-01)

Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis
by: Hanna Schratter, et al.
Published: (2025-02-01)

Pustular Psoriasis: The Dawn of a New Era
by: Hervez Bachelez
Published: (2020-01-01)

Assessment of flare frequency and severity of generalized pustular psoriasis in Japanese patients: A retrospective chart review study
by: Akimichi Morita, et al.
Published: (2023-06-01)

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
by: Talamonti M, et al.
Published: (2023-04-01)

Successful treatment of generalized pustular psoriasis with guselkumab
by: Martina Part
Published: (2024-12-01)

Ixekizumab as a successful treatment in pediatric generalized pustular psoriasis
by: Maria Esposito, et al.
Published: (2025-02-01)

Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date
by: Rega F, et al.
Published: (2024-03-01)

Secukinumab
by: Nilgün Atakan
Published: (2022-04-01)

Efficacy and Safety of Bimekizumab in Japanese Patients with Generalised Pustular Psoriasis and Erythrodermic Psoriasis: 3-Year Results from BE BRIGHT, a Multicentre, Open-Label, Phase 3 Study
by: Yukari Okubo, et al.
Published: (2025-08-01)

Issues of the diagnostic and treatment of generalized pustular psoriasis
by: Violetta A. Kovtunova, et al.
Published: (2024-06-01)

Case report: Intralesional secukinumab injection for pediatric nail psoriasis: does it have to be a positive outcome?
by: Xuesong Wang, et al.
Published: (2024-10-01)

Secukinumab Therapy in Psoriasis Management
by: Ira Yunita, et al.
Published: (2022-03-01)

Pustular Psoriasis: From Pathophysiology to Treatment
by: Giovanni Genovese, et al.
Published: (2021-11-01)

Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search
by: Lluís Puig, et al.
Published: (2024-08-01)

The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
by: Jason E. Hawkes, et al.
Published: (2023-11-01)

Pustular psoriasis of pregnancy: current perspectives
by: Trivedi MK, et al.
Published: (2018-02-01)

Secukinumab‐induced lichen planus
by: Jihane Belcadi, et al.
Published: (2024-06-01)

A Review of the Safety of Interleukin-17A Inhibitor Secukinumab
by: Vishnu Eshwar, et al.
Published: (2022-11-01)

Herpetiform aphthous ulcerations induced by secukinumab: Report of 2 cases
by: Michael Benzaquen, MD, et al.
Published: (2020-10-01)

Atypical oral candidiasis in a psoriatic patient during targeted immunotherapy with an interleukin 17 inhibitor (secukinumab)
by: Bruna Lavinas Sayed Picciani, et al.
Published: (2021-06-01)

The significance of secukinumab in the treatment of plaque psoriasis
by: Marta Kasprowicz-Furmańczyk, et al.
Published: (2022-02-01)

Efficacy of interleukin-17 inhibitors in psoriasis patients: a comparative non-randomized study
by: Arfenya E. Karamova, et al.
Published: (2025-06-01)

Awareness of the Risk of Paradoxical Psoriasis in Patients with SAPHO Syndrome Undergoing Treatment with Secukinumab: A Case Series
by: Xu C, et al.
Published: (2025-03-01)

Generalized pustular psoriasis in a toddler with IL36RN mutation: a case report
by: Ghaith Adi, et al.
Published: (2024-03-01)

Characteristics of Patients with Generalized Pustular Psoriasis: A Report of the Polish Generalized Pustular Psoriasis Group
by: Marta Kołt-Kamińska, et al.
Published: (2024-11-01)

Natalizumab-Induced Pustular Psoriasis of Palms and Soles
by: Bengisu Ozarslan, et al.
Published: (2022-05-01)